Coastlands Capital Buys 53,094 More BOLT Shares for $310K
BOLT sits 78% above its 52-week low of $3.1 on light trading volume (0.3× avg).
Summary
10% owner Coastlands Capital bought another 53,094 Bolt shares for $309,922 at $5.75-$5.89, raising its stake to 515,510 shares — a second open-market tranche in a week, just after the company disclosed a going-concern warning.
Key Events · Ownership and Investor Activity · BOLT
-
Coastlands Adds 53,094 Shares
10% owner Coastlands Capital bought 53,094 common shares in two open-market transactions on 2026-11-16 and 2026-11-17 at $5.75-$5.89, totaling $309,921.66.
-
Stake Rises to 515,510 Shares
Post-transaction indirect holdings via Coastlands Capital LP stand at 515,510 shares.
-
Second Tranche in a Week
Follows a 50,000-share purchase at a weighted-average $6.38 disclosed 2026-11-10; the new tranche is larger and priced lower.
-
Buying Against Going-Concern Backdrop
The purchase lands days after the Q3 10-Q disclosed a going-concern warning even with the $120.0 million October private placement.
Analysis · BOLT · Life Sciences
Coastlands Capital, already a 10% owner, added 53,094 shares for $309,922 in the open market on November 16-17 at $5.75-$5.89, lifting its stake to 515,510 shares. This is real cash out of pocket, not an option exercise, and it follows a 50,000-share purchase disclosed November 10 — a second tranche in a week. The buying comes days after Bolt's Q3 10-Q carried a going-concern warning despite the $120 million October private placement, so an existing large holder adding at these levels is a notable vote of confidence against that backdrop. The caveat is that Coastlands is a financial investor, not an operator, so the read-through is weaker than an executive purchase would be.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BOLT was trading at $5.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.7M. The 52-week trading range was $3.10 to $7.78. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.